Você está na página 1de 9

Downloaded from aim.bmj.com on June 5, 2014 - Published by group.bmj.


Original paper

Role of acupuncture in the
management of diabetic painful
neuropathy (DPN): a pilot RCT
Adam P Garrow,1,2 Mei Xing,1,3 Joanne Vere,1 Barbara Verrall,1
LiFen Wang,1,4 Edward B Jude1,5


Tameside Hospital NHS
Foundation Trust, Diabetes
Centre, Tameside General
Hospital, Ashton-Under-Lyne,
Greater Manchester, UK
The University of Manchester,
School of Nursing, Midwifery
and Social Work, Manchester,
Greater Manchester, UK
The University of Salford,
School of Health Sciences,
Salford, UK
Christie Hospital NHS Trust,
Manchester, Greater Manchester,
School of Clinical and
Laboratory Sciences, The
University of Manchester,
Manchester, Greater Manchester,
Correspondence to
Dr Edward Bernard Jude,
Tameside Hospital NHS
Foundation Trust, Diabetes
Centre, Tameside General
Hospital, Ashton-Under-Lyne,
Greater Manchester OL6 9RW,
UK; edward.jude@tgh.nhs.uk
Received 17 November 2013
Revised 7 February 2014
Accepted 10 February 2014
Published Online First
21 March 2014

To cite: Garrow AP, Xing M,
Vere J, et al. Acupunct Med


Aims To examine the role of acupuncture in the
treatment of diabetic painful neuropathy (DPN)
using a single-blind, placebo-controlled RCT and to
collect data that would be required in a future
definitive study of the efficacy of acupuncture in
Methods 45 patients were allocated to receive a
10-week course either of real (53%) or sham
(47%) acupuncture. Five standardised acupuncture
points on the lower limb of each leg were used in
the study: LR3, KI3, SP6, SP10 and ST36. Outcome
measures included the Leeds Assessment of
Neuropathic Symptoms and Signs (LANSS) scale,
lower limb pain (Visual Analogue Scale, VAS);
Sleep Problem Scale (SPS); Measure Yourself
Medical Outcome Profile (MYMOP); 36-item Short
Form 36 Health Survey and resting blood pressure
Results Over the 10-week treatment period, small
improvements were seen in VAS −15 (−26 to
−3.5), MYMOP −0.89 (−1.4 to −0.3), SPS −2.5
(−4.2 to −0.82) and resting diastolic BP −5.2
(−10.4 to −0.14) in the true acupuncture group. In
contrast, there was little change in those receiving
sham acupuncture. A moderate treatment effect in
favour of active acupuncture was detected in
MYMOP scores −0.66 (−0.96 to −0.35) but nonsignificant effect sizes in LANSS Pain Scale −0.37
(−2.2 to 1.4), resting diastolic BP −0.50 (−3.0 to
1.99) and the SPS −0.51 (−2.2 to 1.16).
Conclusions We have demonstrated the
practicality and feasibility of acupuncture as an
additional treatment for people with DPN. The
treatment was well tolerated with no appreciable
side effects. Larger randomised trials are needed to
confirm the clinical and cost-effectiveness of
acupuncture in the treatment of DPN.
Trial registration number ISRCTN number:

Diabetic painful neuropathy (DPN) is a
distressing and disabling complication of

diabetes mellitus. A recent study showed
that nearly one-third of patients with type
2 diabetes have DPN.1 The causes of this
condition are not yet fully understood,
but age, duration of diabetes and diabetes
control have all been shown to be associated with DPN.1 Typical symptoms
include nocturnal burning or shooting
pains in the legs and feet, indicating
impairment or damage to small nerve
fibres. Symptoms often persist for years
and are associated with disrupted sleeping
patterns and a poor quality of life.2 No
treatment that can reverse the development or progression of diabetic peripheral
neuropathy is available.3 Treatment, therefore, relies on the use of medication to
manage the pain. The most commonly
prescribed drugs for DPN are tricyclic
Clinical trials have shown these drugs to
be effective in controlling the pain but
they have important side effects, including
dizziness and nausea. Up to two-thirds of
patients may have at least one side effect
from taking these drugs, of which 15%
will be serious enough for them to stop
taking the drugs, leaving them with no
effective treatment.4 A number of other,
non-pharmacological treatments have
been tried, including the application of
topical capsaicin and opsite film dressing.
Although there is some evidence that capsaicin can lead to a reduction in pain
score, the effectiveness of topical treatments is yet to be determined.5
Acupuncture has been shown to be
effective in treating back pain and shoulder
pain.6 7 There is also some evidence that it
may be beneficial in the management of
peripheral neuropathy and painful neuropathy in diabetes.8–10 However, the evidence to support this use of acupuncture is
deficient because of poor methodology,

Garrow AP, et al. Acupunct Med 2014;32:242–249. doi:10.1136/acupmed-2013-010495

having at least one palpable pedal pulse per foot. For example.11 12 To date. a computer-generated randomised list of numbers was prepared allocating participants to receive either real or sham acupuncture. The study also considered a range of different outcomes for their suitability for a future definitive clinical trial. measured with a neurosthesiometer. Study design Before the recruitment. LR3. 2014 . The chosen points are based on traditional Chinese medicine diagnosis for diabetes and neuropathy—that is. and to derive point and variability estimates to inform future sample size calculations.5–1. Two of the acupuncturists (BV and LFW) were UK trained with nearly 10 years’ experience of treating patients in the NHS and in private practice. the sham needle. Weekly afternoon clinics were arranged allowing sufficient time for the collection of study outcome data and for the acupuncture treatments to be completed. but was usually 0.Published by group. with a clinical diagnosis of DPN and taking a prescribed drug for DPN were identified from primary and secondary care patient databases and invited to attend a screening visit held in the recruiting centre of a local district general hospital. Korea). Acupunct Med 2014. SP6.8 9 17 18 The point location and depth of needle insertion were based on traditional acupuncture methods and good clinical practice.32:242–249.bmj.com Original paper variability of treatment protocols and small sample sizes. impaired light touch (10 g monofilament)15 or a vibration perception threshold on either foot >25 V. de qi and blood stagnation. The study was approved by the north west ethics committee (ref: 08/H1011/16A) and all patients gave written informed consent before taking part in the study. both the real and sham disposable needles look identical.bmj. ISRCTN Number: 39740785. being free of foot ulcers at the start of the study and having signs of peripheral sensory neuropathy. These acupuncture points have also commonly been used in other similar clinical studies. The treatment allocation was revealed to the acupuncturists out of sight of the participants to ensure blinding.1136/acupmed-2013-010495 Figure 1 Acupuncture points. Other inclusion criteria were patients taking a prescribed drug for their neuropathic pain. which has been validated for use in randomised clinical trials.Downloaded from aim. A total of five standardised acupuncture points on the foot and lower limb of each leg (total 10) were used in the study. most studies have concentrated on the analgesic properties of acupuncture. She has also been a senior lecturer in traditional Chinese medicine and acupuncture since 2001. PATIENTS AND METHODS Sixty-five patients with type 1 or type 2 diabetes. not having previously received acupuncture treatment for DPN. 243 . The allocation was placed inside sequentially ordered sealed opaque envelopes. a meta-analysis of 29 acupuncture RCTs in the treatment in chronic pain showed that acupuncture produces small but clinically relevant reductions in pain. opened only after enrolment. doi:10.25–2 cm).20 In brief. A series of training sessions were carried out before the start of the study to allow practitioners to become familiar with the sham acupuncture devices and to standardise point location and technique. the acupuncture practitioners were discouraged from discussing the treatments or previous results with the patients. Garrow AP. The acupuncture treatments were carried out by any one of three trained acupuncturists who were either members of the British Acupuncture Council or the Acupuncture Association of Chartered Physiotherapists. aged between 18 and 80 years. The sham device used in the study was the Park sham device (Dong Bang Acupuncture Inc. The third practitioner (MX) was trained in integrated medicine in China and has worked as a consultant doctor in Western and Chinese medicine. To reduce the risk of observer bias.13 The objective of this sham-controlled single-blind RCT was to examine the practicality and feasibility of integrating acupuncture into the management of lower limb painful neuropathy in diabetes.16 Data were collected between July 2008 and March 2010. kidney deficiency. defined as the absence of any two of sharp/blunt sensations (measured using a NeuroTip)14. KI3. et al.com on June 5. SP10 and ST36 (figure 1).5 cun (about 0.19 The depth of needle insertion varied according to point.

25 General health status was measured using the 36-item Short Form 36 Health Survey (SF-36). a mental health score and a bodily pain score (BPS). et al. We did not ask patients whether they felt de qi to avoid the risk of patients in the placebo group becoming unblinded to their treatment allocation.30 Group differences between the means are presented together with their 95% CIs. a sliding plastic tube is adhered to each of the acupuncture points to mask the allocation of needles from the patients. Baseline characteristics are presented using means and SDs and categorical data are presented as proportions. systolic and diastolic blood pressures were recorded before each acupuncture treatment. week 5 and week 10. Last observation carried forward was used to replace missing values. Our target sample of 60 people was based on the recommendations of Lancaster et al. a short standardised measure of sleep disturbance. χ2 Tests were performed on categorical data and t tests on continuous variables. which is in keeping with normal acupuncture practice. The proportions in each group showing at least a 25% improvement in LANSS and VAS pain scores were also compared. an effect size estimate comparing real and sham acupuncture groups was calculated as the difference between the 10-week mean values divided by the pooled SD. The protocol permitted changes in medication as required.4–0. 0. doi:10. there is now some evidence and growing interest in the potential benefits of acupuncture in the management of hypertension. Acupunct Med 2014. SPS and SF-36 were completed at the baseline visit. In addition.1136/acupmed-2013-010495 . which produces three subscale scores: physical health score. The analyses were conducted on an ‘intention-to-treat’ basis. As outcome values were likely to be strongly correlated with baseline values.bmj. a primary outcome measure and a formal power calculation were not required. Lower limb pain intensity was measured on a 100 mm Visual Analogue Scale (VAS). Sleep quality was assessed using the Sleep Problem Scale (SPS).com on June 5.Published by group.com Original paper however. analyses of covariance were carried out. and the Measure Yourself Medical Outcome Profile (MYMOP) was used to measure changes in health over time.Downloaded from aim.7 considered moderate and >0.4 considered small effects. The maximum score on the LANSS scale is 24. In addition. with scores >12 indicating that neuropathic mechanisms are likely to be contributing to patients’ pain. patients were provided with a telephone number to report any concerns they had about the study. all patients had their blood pressure taken before and after treatment and completed a copy of the MYMOP and a VAS for pain. with values ≤0. to determine whether the event was related to the acupuncture treatment. All patients were provided with a patient information sheet which informed them that they were taking part in a randomised trial in which they could be treated with real acupuncture or an inactive treatment that looked like real acupuncture. Assessments of neuropathic pain were carried out using the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale.31 RESULTS Study sample All patients were enrolled into the study within the 18-month target recruitment period. patients were asked if they had had any side effects as a result of the acupuncture treatment. Statistical analysis We considered the availability and willingness of patients to be recruited. All patients with suspected adverse events received a referral appointment with the study principal investigator. Although the main focus of this study was to examine the benefits of acupuncture for the treatment of DPN. Before needling. including those taken for DPN.19 The intervention consisted of a total of 10 weekly sessions during which diabetes and blood pressure management continued as normal. a consultant in diabetes. Outcome measures Power calculation and sample size As this was a feasibility study. the number of adverse events and losses to follow-up.26 At each study visit. is blunt and slides into the handle rather than penetrating the skin when the needle is tapped. For each of the outcome measures.23 The instrument contains questions pertaining to five neuropathic sensory disturbance domains and two sensory examination items. 2014 . Outcomes selected for this study were based on measures used in previous studies of DPN.bmj.7 considered large effects.29 244 Adverse event reporting At the beginning of each study visit. the LANSS has been used as an outcome measure in previous neuropathic pain RCTs. Any adverse events were recorded on the case report forms and reported to the principal investigator (EBJ) and the research and development department according to the hospital’s standard operating procedures. They were also informed that they would not be told which treatment they had received until all study visits had been completed.21 After insertion. The primary Garrow AP. the LANSS pain scale. As this was a feasibility study.32:242–249.27 28 As resting blood pressure is routinely measured in the diabetic clinic. The instrument was developed specifically for use in studies of complementary medicine24 and collects information on symptoms considered by the patient to be important.22 Although originally developed as a screening instrument. the needles remained in place for 30 min and both real and sham needles were manipulated after 15 min. a power calculation was not required.

2% deterioration in LANSS symptoms (table 2). Thirteen of 28 (46. The baseline demographic and clinical characteristics are displayed in table 1. A total of four patients in the active group and 10 patients in the sham group failed to complete the study (figure 2). One person in the sham group stopped taking their medication owing to low blood pressure.32:242–249. SD)‡ VAS pain score (median. Adverse events In total. Measure Yourself Medical Outcome Profile.com on June 5. BP. Visual Analogue Scale.com Original paper care medical staff and administrators supported the project and readily agreed to identify potentially suitable patients from the databases. those in the sham group showed a 7. Leeds Assessment of Neuropathic Symptoms and Signs.2 (7. we were unable to determine whether these differences influenced the results of the study.1 (1. Garrow AP. In the group receiving active treatment. IQR) 13 (7–20) 12 (6–16) MYMOP (mean. SD) 4. resulting in 59 being enrolled into the study. Overall.1136/acupmed-2013-010495 incidents of infections associated with the administration of acupuncture were seen or reported. The largest change seen in the sham group was a 6. ‡Vibration perception assessed using a neurothesiometer. related to a chronic heart condition. IQR) 15 (10–19) 14 (9–19) Sleep Problem Scale (median. Of the 65 patients considered eligible. In the analysis of covariance.3) Diastolic BP (mean. No Table 1 Baseline characteristics of patients randomised into groups who received real or sham acupuncture treatment Characteristics Sham (n=21) Active (n=24) Age (mean. make the initial contact with the patients and send out the patient information sheets.1 points more in the treatment group than the sham group which would be considered as a moderate treatment effect (table 3). one participant withdrew because she developed a localised swelling in her leg. Sham group participants also showed improvements in VAS score.4) White British (%) 81 100 Married (%) 76 79 Retired (%) 52 63 At least one palpable pedal pulse on either 100 100 foot (%) Bilateral impaired sharp/blunt sensation (%)* 89 96 Bilateral impaired light touch sensation (%)† 30 29 Vibration perception threshold (VPT) (right) 27 (8.0 (9.8) 68 (11.4 (1.Downloaded from aim.1) Male (%) 71 67 Type 2 diabetes (%) 95 96 Diabetes duration years (mean. et al. three adverse events were reported resulting in patients withdrawing from the study.4%) in the group receiving active treatment showed at least a 25% improvement in VAS pain intensity score compared with four of 31 (12. The patients who received active acupuncture were slightly older and also had higher levels of sensorimotor impairment.bmj. Bias resulting from inadequacies in blinding could lead to exaggerated 245 . Because of the small numbers.5) *Light touch sensation assessed using a 10 g monofilament. SD) 63 (10.32 This study has provided a model of how acupuncture can be easily incorporated into the routine management of people with DPN. SPS and diastolic blood pressure.bmj. Forty-five (76%) patients completed a baseline and final assessment: 24 (53%) received active acupuncture and 21 (47%) sham acupuncture treatment.3) 4. Improvements were also seen for SF-36 physical component and BPS and systolic blood pressure. MYMOP score. the LANSS score improved by an average of 2. LANNS.2) Systolic BP (mean. Acupunct Med 2014.Published by group. Acupuncture was also well tolerated by patients with few if any side effects. VAS.9%) in the sham treatment group. In contrast. In the sham group. Patients in the active acupuncture group showed a 16% improvement in LANSS score after acupuncture.2) 12.3 unit improvement in SF-36 BPS (table 2). None of the patients changed their neuropathic pain medication during the 10-week study period. the non-completion rate was in line with expectation but found to be higher amongst those allocated to receive sham treatment. The study was carried out on a fairly typical sample of patients with long-term DPN who might be found in primary and secondary care. suggesting that it is a safe treatment. doi:10. resting blood pressure and SPS but these were much smaller than those found in the active treatment group. and another withdrew as she felt that the acupuncture exacerbated her leg pain. SD) 131 (19.7) (mean. MYMOP. improvements over 10 weeks were found for VAS pain intensity. SD) 11. In the active acupuncture group. six refused.0) 75 (9. one participant developed chest pains while undergoing acupuncture treatment.2) 137 (14. Blood Pressure. DISCUSSION This is one of very few studies that have investigated the role of acupuncture in the management of lower limb DPN. Six of 24 (25%) patients in the active acupuncture group showed at least a 25% improvement compared with four of 21 (19%) in the sham group. Two patients in the group receiving active acupuncture had their blood pressure medication stopped owing to low blood pressure and two patients had their medication dose increased. which was considered unrelated to the study. †Impaired sharp blunt sensation assessed using a NeuroTip. IQR) 70 (50–80) 78 (70–90) LANNS pain scale (median. SD) 78 (10. This report follows STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) guidelines. 2014 .1) 33 (10.

This result may occur because the BPS items relate to general pain changes in the Garrow AP. doi:10.Downloaded from aim. results which suggest that the sham treatment was relatively therapeutically inactive. it is unlikely. The exception to this was the SF-36 BPS. which showed a small six-unit improvement over 10 weeks.1136/acupmed-2013-010495 .34 35 246 The results are also consistent with the findings of a recent systematic review of the analgesic effects of acupuncture in chronic pain.Published by group.com on June 5. over 90% of patients had loss of sharp/blunt and light touch sensation in their lower limbs (table 1).bmj. therefore.13 It has previously been suggested that nonpenetrating sham needles could cause some level of sensory stimulation when the needles are tapped and rotated and therefore stimulate the acupuncture points. Acupunct Med 2014.bmj. treatment effects.com Original paper Figure 2 Flow chart of patients through the trial. participants were asked whether they thought they had received active or sham treatment. The study included only 59 participants and therefore some of the results may be susceptible to type II errors —that is. These data suggest that our results were not unduly biased owing to any blinding effects. Evidence for this is provided in table 2. Our findings showing small to moderate treatment effects of active acupuncture are comparable with randomised studies of headache and low back pain. however. Forty per cent in the active acupuncture group thought they had received sham treatment and 42% in the sham group thought they received real treatment. but not in the sham group. which shows only small changes in eight of the nine outcome measures in the sham group between baseline and 10 weeks.32:242–249. suggest that acupuncture may have a role in the treatment of some of the unpleasant symptoms associated with DPN.33 In a post hoc analysis 3 months after their final treatment.36 In this study. Observed improvements in the active acupuncture group. 2014 . et al. that the study patients would have been able to differentiate between real or sham needles. the sample size was too small for the observed differences between groups to appear statistically significant.

9) −2.6 (8. previous month and therefore BPS is likely to reflect the episodic nature of chronic musculoskeletal pain commonly found in people of this age.7 (−6.6) 138 (14.1 (12.8 to 8. LANNS.9 (9.8 (6.6 (−2.7 to 15.1) −15 (−26 to −3. Short Form 36.1 (−1.32:242–249.5 (−4.1 to 0.05) Change score (95% CI) −0.Published by group. BP.Downloaded from aim.5 to 1.3 to 5.4) Sleep Problem Scale Baseline 13.9 (20.5) Change score (95% CI) −0. Garrow AP.2) −0.4) Resting systolic BP Baseline 132 (17.6) −1.3) 6.1 to 5.0) 10-Week follow-up 31.3 to 11. were reported in the findings of a systematic review of 11 studies.2) 1.2 (20.2 to 0.6) 39.2 (7.5) 7 (−4 to 19) MYMOP scores Baseline 4.2) 4. Similar results.77) Change score (95% CI) −0.2 (7.5 (10.6) 10-Week follow-up 13. VAS.6 (−2.4 (−12.5 (−5.1) 12.com Original paper Table 2 Changes in outcomes between baseline and 10-weeks group differences (mean and SD) Outcome measures Sham Active Difference (95% CI) LANNS scores Baseline 15.2 (14.7 (13.2 (−10.9 to 0.71) 10-Week follow-up 4.97 (−4.7 to 3.4 to −0.7 (12. Although the attendance was in line with expectations.8 to 5.7 to 10.8 to 8. Blood Pressure.82) 2.5 to 2.3 (−4.2 (−5.7 (−6.0 to 2. however. doi:10.2) 6.1 (−5.2 (6.37 Our results also suggest that the 10-week course of acupuncture may lead to a 5 mm Hg reduction in diastolic blood pressure.2) 2. et al.19) Change score (95% CI) −0.4 (1.4 to −0.8) SF-36 bodily pain score Baseline 27.4) −0.9) 37.3) −0.2) VAS scores Baseline 67 (19) 73 (24) 6 (−5 to −17) 10-Week follow-up 62 (23) 58 (26) −4 (−17 to 9) Change score (95% CI) −5 (−11 to 1.06 (−2.1) 3. The evidence for the efficacy of acupuncture in controlling blood pressure is controversial and inconclusive.4 (−7.0) 0. such as the use of reminder texts and telephone calls.5) −5.16 (−5.4 to −0.1 (−1.89 (−1.7 (27.4 to −0.3 (19.4) 40.5) SF-36 mental component score Baseline 36.003 (−0.1 to 7.8 (14.bmj.7) 1.1 (−3. Visual Analogue Scale.03 (−0.7) 1.8 (−7.2 (−4. As our results suggested improvements in a variety of troublesome symptoms.1) Change score (95% CI) −2.4) Change score (95% CI) 6.3 to 1.4 10-Week follow-up 35.6) 10-Week follow-up 16.43 to 0.38 Although our results should be treated with caution.1 to 22.4 to 1.7) Change score (95% CI) −0.7 to 3.4) Resting diastolic BP Baseline 77 (8.85 (0.4) 9.8) Results are shown as mean (SD) or mean (95% CI).2) −2.67 (−2.2 (−10. 247 .5 (−5. SF-36.07 (−0.5 to 2.3 (6.8 to 17. Measure Yourself Medical Outcome Profile.1 to 9.4 to 4.0) 3.9 (−4.3 (−4.3) Change score (95% CI) 1.1) −0.6 (−0.com on June 5.74) −5.7) 2.bmj.7 to 1. they do support the inclusion of blood pressure as an outcome in future acupuncture studies.2 to 5.2) 13.7) 75 (9.7 (−1.5 to 1.6 to 10.6 (−6.8) 31.1136/acupmed-2013-010495 This study has shown that acupuncture can be successfully incorporated into the management of patients with DPN.2 (1.9) −2.5) 2.8 (−1.3) 4.1 to 1.1) 10-Week follow-up 131.3 (1.2 (7.2 to −0. Leeds Assessment of Neuropathic Symptoms and Signs.4 (−6.2 (−10.3) 10-Week follow-up 33. MYMOP.8) −0.7 (0.1 (−2.7) −1.9) 40. Acupunct Med 2014.42) −0.7) −3. in future studies we would recommend the adoption of additional measures to reduce the non-attendance rate.2) 0.8 to 10.4) 10.2 (1.7) 133.4) 70 (10.2) SF-36 physical component score Baseline 32.3) 0.5 to 2.42 (−3.4) −2.0) 14.3 (6.58 to 0.1 (9. future studies should collect information on the different signs and symptoms associated with DPN rather than concentrating on detecting unit reductions in pain intensity.3) 33.6 to 1.8) 10-Week follow-up 75 (9.2) −5. 2014 .14) 4.7 (16.6 (7.7 to 17.5 (−3.

2 to 1. JAMA 1998. et al. Max MB. Summary points ▸ Painful diabetic neuropathy is difficult to treat.51 (−2. Correction notice This article has been corrected since it was published Online First. Diabetes Res Clin Pract 1998. 248 2 Zelman DC.34:2220–4. Diabet Med 2002. Maschino AC.6) SF-36 bodily pain score 0. Watson P.9 to 5. Gore M. Provenance and peer review Not commissioned. Han B. Guo H.2 to 1. VAS. externally peer reviewed. and the American Academy of Physical Medicine and Rehabilitation. Contributors All authors contributed to the design of the pilot RCT. Brandenburg NA.96 to −0.1 to 3. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy.4 to 6. Acupunct Med 2002. 6 Kleinhenz J. The findings of this study will be useful in the planning of larger RCTs that are needed to determine the therapeutic and cost-effectiveness of acupuncture in the treatment of DPN. PLoS ONE 2013.(3):CD007938. Validating a new non-penetrating sham acupuncture device: two randomised controlled trials. Clin J Pain 2006. All other authors contributed and approved the final version of the manuscript.90:1–7.8: e73764. MYMOP. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cronin AM. Pain 1999.26 (−3. White A. the American Association of Neuromuscular and Electrodiagnostic Medicine. APG produced draft copies of the manuscript and the final version for submission.K.3:95–103. Ashe H. new diabetic foot ulceration in a community-based patient cohort. ▸ We tested the feasibility of a sham-controlled acupuncture trial. 3 Boulton AJ. 20 Park J.4) SF-36 physical component score 0. Manual acupuncture for treatment of diabetic peripheral neuropathy: a systematic review of randomized controlled trials. Malik RA. A systematic review of experimental and clinical acupuncture in chemotherapyinduced peripheral neuropathy.22 (−2. 18 Shlay JC. Tobin I. Wiffen PJ.83:235–41.0 to 1. et al. et al.11:1590–5. et al.1) Resting systolic blood pressure 0. 13 Vickers AJ. Sleep impairment in patients with painful diabetic peripheral neuropathy. 14 Abbott CA. 2nd edn.25:11–17.com Original paper Table 3 Standardised mean difference (effect size) comparing active acupuncture with sham acupuncture at the 10 week visit Outcome measures Standardised mean differences 95% CI MYMOP −0. 19 Deadman P. Yang G-Y. The diabetic foot: from art to science. EBJ is guarantor of the paper taking responsibility for the integrity of the work as a whole from inception to published article. doi:10.32:242–249. and risk factors for.08 (−4. Windeler J. Measure Yourself Medical Outcome Profile. 16 Garrow AP.bmj.Downloaded from aim.4:345–52. ▸ Patients were willing and standardised treatment was deliverable in the diabetic clinic. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study.1136/acupmed-2013-010495 .66 (−0. et al. The views expressed are those of the author(s) and not necessarily those of the NHS.5 (−3. et al.47:1343–53. Arch Intern Med 2012.4) Lower limb VAS −0. 15 Tan LS. Competing interests None. ▸ Improvements in symptoms were promising. The clinical use of the 10 g monofilament and its limitations: a review.16 (−6. Streitberger K.6) LANSS. Figure 1 has been amended. et al. USA.29:230–3. Derry S. CA 92081. Vibration perception threshold–a valuable assessment of neural dysfunction in people with diabetes.6 to 4.19:377–84. 9 Tong Y. Cochrane Database Syst Rev 2011. Manual of acupuncture.22:411–19. Diabetologia 2004. Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. 10 Ahn AC. BMJ 2009. Visual Analogue Scale.com on June 5. Randomised clinical trial comparing the effects of acupuncture and a newly designed placebo needle in rotator cuff tendinitis.7) SF-36 mental component score 0. Funding This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (grant reference number PBPG-0706-10595). et al. Acupuncture for chronic pain: individual patient data meta-analysis.99) Sleep Problem Scale −0. Schröder S. Early management of persistent nonspecific low back pain: summary of NICE guidance. the NIHR or the Department of Health.37 (−2. Diabetes Care 2011. REFERENCES 1 Abbott CA. The 18th Camillo Golgi lecture. Vista: Eastland Press. van Ross ER. Stringer J. Baker K. 4 Moore RA.20:168–74.2013:1–7. Garrow AP. Ethics approval Ethical approval was obtained from the north west ethics committee (ref: 08/H1011/16A). England J. Liu B. 17 Donald GK.30 (−4. 8 Abuaisha BB. J Acupunct Meridian Stud 2010. Al-Khafaji M. ISRCTN number: 39740785. et al. et al. et al. Boulton AJ. Bennani T. 2014 . Evid Based Complement Alternat Med 2013. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American Academy of Neurology.bmj. The North-West Diabetes Foot Care Study: incidence of.39:115–21. Acupunct Med 2014.338:b1805. Freeman R. Chaloner K.16) LANSS pain scale −0.35) Resting diastolic blood pressure −0. Costanzi JB. Terry Beirn Community Programs for Clinical Research on AIDS. Boulton AJ. Acupunct Med 2007. Franklin GM. Two styles of acupuncture for treating painful diabetic neuropathy—a pilot randomised control trial. Underwood M. 2003. 12 Franconi G. Neurology 2001. 11 Chen W. J Acupunct Med 2011. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.172:1444–53. Short Form 36. 5 Bril V. and a trial feasible. Manni L. SF-36. Stevinson C. Diabetes Metab Res Rev 2006. APG and EBJ performed the statistical analysis.22:681–5. 7 Savigny P. Leeds Assessment of Neuropathic Symptoms and Signs. Carrington AL. Diabetes Res Clin Pract 2010. et al.Published by group.2 to 2. Fifteen-day acupuncture treatment relieves diabetic peripheral neuropathy.

Forsch Komplementarmed Klass Naturheilkd 2003. Effectiveness of gabapentin in the treatment of chronic post-thoracotomy pain.3:140–55. Altman DG. Meissner K. Eur J Cardiothorac Surg 2007. Zhao L. Foy C. BMC Med 2010. et al. A scale for the estimation of sleep problems in clinical research. Esme H. 30 Vickers AJ. et al.30:473–83. The MOS 36-item short-form health survey (SF-36). Acupuncture Randomized Trials (ART) in patients with migraine or tension-type headache--design and protocols. Zheng H. et al.com on June 5. Sherbourne CD. Bäumler P. Egger M. 22 Bennett M.10:2–9.32:242–249. et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement. 35 Brinkhaus B. doi:10.323:1123–4. Gefeller O. 27 Flachskampf FA. 37 Donald IP. Park J. et al. How large are the nonspecific effects of acupuncture? A metaanalysis of randomized controlled trials. Schneider A.10:307–12. BMJ 2001. Streng A.17:259–64. Metin M. Circulation 2007. J Evid Based Med 2010. 32 MacPherson H. et al.166:450–7. 33 Wood L. Williamson PR. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Randomized trial of acupuncture to lower blood pressure. 34 Melchart D.336:601–5. BMJ 1996.92:147–57. Statistics notes: analysing controlled trials with baseline and follow up measurements. et al. Conceptual framework and item selection. Deqi sensations without cutaneous sensory input: results of an RCT. Am J Hypertens 2009. compared with the SF-36 health survey. et al. Stanton BA. 23 Solak O. BMC Complement Altern Med 2010. MYMOP. Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial. BMJ 2008.32:9–12. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.Downloaded from aim. Gallasch J. Linde K. Acupuncture in patients with chronic low back pain: a randomized controlled trial.bmj. J Clin Epidemiol 1988. Niemann K. Trials 2013. Gluud LL. Forsch Komplementmed 2010. Acupunct Med 2014.8:75. et al. Simang M. 38 Lee H. STRICTA Revision Group. 26 Ware JE Jr. Pain 2001.22:122–8. Med Care 1992.43:1256–60. Jena S. Rheumatology (Oxford) 2004. et al. Witt CM.312:1016–20. Arch Intern Med 2006.. 24 Paterson C.com Original paper 21 Salih N. A longitudinal study of joint pain in older people.1136/acupmed-2013-010495 31 Linde K. 28 Li J. Altman DG.10:179–84. 29 Lancaster GA. Niemcryk SJ. Dodd S. et al. Niemann K. Kim SY. Acupuncture for lowering blood pressure: systematic review and meta-analysis.bmj. Design and analysis of pilot studies: recommendations for good practice. 25 Jenkins CD. Measuring outcomes in primary care: a patient generated measure. Are sham acupuncture interventions more effective than (other) placebos? A re-analysis of data from the Cochrane review on placebo effects. 249 .41:313–21. Hammerschlag R. J Eval Clin Pract 2004. Garrow AP.14:1–10. 2014 .115:3121–9.Published by group. 36 Linde K.

Further reproduction prohibited without permission. .Reproduced with permission of the copyright owner.